Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Sutro Biopharma, Inc. (S09.F) Follow Compare 0.4700 -0.0216 (-4.39%) At close: 3:29:01 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for S09.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: S09.F View More All News Press Releases SEC Filings Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls Sutro Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025 Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls Sutro Biopharma downgraded to Neutral from Overweight at Piper Sandler Sutro Biopharma Inc (STRO) Q4 2024 Earnings Call Highlights: Strategic Focus and Financial ... Sutro Biopharma Falls as Company Cuts Workforce, Shifts Focus to ADCs Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’ Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline Related Tickers GBY.MU Sangamo Therapeutics Inc 0.6266 -2.66% EDIT Editas Medicine, Inc. 1.2800 +0.79% ABCL AbCellera Biologics Inc. 2.4200 +1.26% CRSP CRISPR Therapeutics AG 37.77 -0.03%